Synthetic microbial consortia for the treatment of Clostridioides difficile infection in mice model

Clostridioides difficile infection (CDI) as of recent has become a great concern to the impact on human health due to its high hazardous risk and rate of recurrence. Live bacterial therapeutics is a promising method to treat or prevent CDI. Here, a synthetic microbial consortia (SMC) B10 was constru...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jinqiu, Zhu, Wei, Lessing, Duncan James, Chu, Weihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527189/
https://www.ncbi.nlm.nih.gov/pubmed/37602713
http://dx.doi.org/10.1111/1751-7915.14333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527189/
https://www.ncbi.nlm.nih.gov/pubmed/37602713
http://dx.doi.org/10.1111/1751-7915.14333

Ejemplares similares